OTCPK:TAFF.F

Stock Analysis Report

Executive Summary

Life Healthcare Group Limited, an investment holding company, provides genetic testing and health data analysis services in the People’s Republic of China and Hong Kong.


Snowflake Analysis

Flawless balance sheet and fair value.

Share Price & News

How has Life Healthcare Group's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: TAFF.F has not had significant price volatility in the past 3 months.


Market Performance


7 Day Return

0%

TAFF.F

13.7%

US Healthcare

10.5%

US Market


1 Year Return

n/a

TAFF.F

-3.4%

US Healthcare

-11.5%

US Market

Return vs Industry: Insufficient data to determine how TAFF.F performed against the US Healthcare industry.

Return vs Market: Insufficient data to determine how TAFF.F performed against the US Market.


Shareholder returns

TAFF.FIndustryMarket
7 Day0%13.7%10.5%
30 Day0%-9.1%-15.4%
90 Dayn/a-18.9%-21.4%
1 Yearn/a-2.2%-3.4%-9.6%-11.5%
3 Yearn/a18.6%13.4%12.6%5.4%
5 Yearn/a23.4%15.1%32.8%18.1%

Price Volatility Vs. Market

How volatile is Life Healthcare Group's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is Life Healthcare Group undervalued compared to its fair value and its price relative to the market?

>50%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: TAFF.F ($0.01) is trading below our estimate of fair value ($0.8)

Significantly Below Fair Value: TAFF.F is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: TAFF.F is unprofitable, so we can't compare its PE Ratio to the Healthcare industry average.

PE vs Market: TAFF.F is unprofitable, so we can't compare its PE Ratio to the US market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate TAFF.F's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: TAFF.F is good value based on its PB Ratio (0.8x) compared to the US Healthcare industry average (3.1x).


Next Steps

Future Growth

How is Life Healthcare Group forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

13.5%

Forecasted Healthcare industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Life Healthcare Group has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

  • Examine whether Life Healthcare Group is trading at an attractive price based on how much it is expected to earn in the future, and relative to its industry peers and the wider market.
  • While we do not consider unaudited financials to be a reliable enough to include in our analysis, you can access them on the OTC Markets Website. If you are looking for more of a qualitative research into the company, you can access Life Healthcare Group's filings and announcements here.
  • Explore growth companies in the Healthcare industry.

Past Performance

How has Life Healthcare Group performed over the past 5 years?

-26.0%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: TAFF.F is currently unprofitable.

Growing Profit Margin: TAFF.F is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: TAFF.F is unprofitable, and losses have increased over the past 5 years at a rate of -26% per year.

Accelerating Growth: Unable to compare TAFF.F's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: TAFF.F is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (6.2%).


Return on Equity

High ROE: TAFF.F has a negative Return on Equity (-24.58%), as it is currently unprofitable.


Next Steps

Financial Health

How is Life Healthcare Group's financial position?


Financial Position Analysis

Short Term Liabilities: TAFF.F's short term assets (HK$222.1M) exceed its short term liabilities (HK$14.7M).

Long Term Liabilities: TAFF.F's short term assets (HK$222.1M) exceed its long term liabilities (HK$2.2M).


Debt to Equity History and Analysis

Debt Level: TAFF.F is debt free.

Reducing Debt: TAFF.F had no debt 5 years ago.


Balance Sheet

Inventory Level: TAFF.F has a low level of unsold assets or inventory.

Debt Coverage by Assets: Insufficient data to determine if TAFF.F's debt is covered by short term assets.


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: Whilst unprofitable TAFF.F has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.

Forecast Cash Runway: TAFF.F is unprofitable but has sufficient cash runway for more than 3 years, due to free cash flow being positive and growing by 60.6% per year.


Next Steps

Dividend

What is Life Healthcare Group's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate TAFF.F's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.

High Dividend: Unable to evaluate TAFF.F's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if TAFF.F's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if TAFF.F's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: TAFF.F is not paying a notable dividend for the US market.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of TAFF.F's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

3.3yrs

Average board tenure


CEO

Life Healthcare Group has no CEO, or we have no data on them.


Board Members

NamePositionTenureCompensationOwnership
Yunbo Hua
Executive Director;3.92yrsHK$2.40mno data
Wai Lun Man
Executive Director1yrHK$29.00kno data
Xueping Xu
Executive Chairman0.17yrno datano data
Chunlei Zheng
Independent Non-Executive Director5.08yrsHK$240.00kno data
Hua Shan
Non-Executive Director4.08yrsHK$2.62mno data
Xinghua Liu
Independent Non-Executive Director3.33yrsHK$240.00kno data
Chun Man Cheng
Independent Non-Executive Director0.58yrno datano data

3.3yrs

Average Tenure

46yo

Average Age

Experienced Board: TAFF.F's board of directors are considered experienced (3.3 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Life Healthcare Group Limited's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Life Healthcare Group Limited
  • Ticker: TAFF.F
  • Exchange: OTCPK
  • Founded: 2001
  • Industry: Health Care Services
  • Sector: Healthcare
  • Market Cap: HK$203.463m
  • Listing Market Cap: HK$26.193m
  • Shares outstanding: 5.35b
  • Website: https://www.lifehealthcare.com

Number of Employees


Location

  • Life Healthcare Group Limited
  • Office A
  • 18th Floor
  • Wan Chai
  • Hong Kong

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
TAFF.FOTCPK (Pink Sheets LLC)YesOrdinary SharesUSUSDApr 2002
928SEHK (The Stock Exchange of Hong Kong Ltd.)YesOrdinary SharesHKHKDApr 2002

Biography

Life Healthcare Group Limited, an investment holding company, provides genetic testing and health data analysis services in the People’s Republic of China and Hong Kong. The company operates through three segments: Healthcare Services Business, Money Lending Business, and Securities Trading and Investments Business, and Others. It offers a range of services and solutions for medical and health administration through its non-invasive tumor genetic testing technology. The company also engages in apparel retail; securities trading and investment; and money lending activities. In addition, it provides corporate administrative and healthcare services. The company was formerly known as Tack Fiori International Group Limited and changed its name to Life Healthcare Group Limited in June 2017. Life Healthcare Group Limited was incorporated in 2001 and is based in Wan Chai, Hong Kong. 


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/01/18 23:50
End of Day Share Price2019/10/21 00:00
Earnings2019/09/30
Annual Earnings2019/03/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.